instruction stringlengths 1.03k 1.87k | output stringlengths 554 1.04k |
|---|---|
SUBJECT: Product A adverse event and both Product A and Methotrexate identified as suspect report
Dear Drug Safety Department,
I am the Consultant Rheumatologist at a pharmaceutical benefit manager and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Urgent adverse event Product A and dual suspect Product A and Omeprazole
Dear Patient Safety Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as contr... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A adverse reaction with suspect Product A with suspect Lisinopril
Dear Pharmacovigilance Team,
I am the Consultant Dermatologist at a childrens hospital outpatient department and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse even... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Adverse event report Product A plus both Product A and Methotrexate identified as suspect
Dear Corporate Drug Safety Department,
I am the Head of Pharmacy Services at a pharmaceutical benefit manager and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Adverse event notification for Product A with Methotrexate excluded as causative agent
Hi,
I am writing as the caregiver for my husband Brandon Sanders to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 59 year old ma... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Urgent adverse event Product A and suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am the Consultant Endocrinologist at a pharmaceutical benefit manager and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event wh... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Safety report Product A and Product B no longer taken
Dear Drug Safety Department,
I am writing as the caregiver for my wife Donna Harris to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 50 year old female patient o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A reaction report with Omeprazole concomitant medication only
To Whom It May Concern,
I am writing as the caregiver for my wife Dennis King to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 53 year old female... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Formal adverse event notification Product A with Product B unchanged during reaction
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Pulmonologist at a respiratory medicine centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adver... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Adverse event report Product A plus Product B taken alongside
Dear Drug Safety Department,
I am the Head of Pharmacy Services at a mental health trust and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patient exp... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A reaction and Product B taken alongside formal notification
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my mother Sharon Patel to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 29... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Adverse event notification for Product A with Product B implicated only as concomitant
Dear Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 67 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction report with concomitant Product B exposure
Dear Global Safety Unit,
I am writing as the caregiver for my father Nathan Bailey to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 60 year old male pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Pharmacovigilance report Product A with Amlodipine also suspected by physician
Dear Drug Safety Department,
I am writing as the caregiver for my wife Nicole Wilson to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating phy... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Suspected adverse event with Product A and ongoing Amlodipine use alongside Product A
Dear Global Safety Unit,
I am the Consultant Pulmonologist at an immunology and allergy clinic and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The pa... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction report with suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am the Consultant Hepatologist at a home healthcare nursing agency and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Adverse reaction report involving Product A and suspect Product B also implicated
Dear Global Safety Unit,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Adverse event report Product A plus dual suspect Product A and Omeprazole
Dear Pharmacovigilance Team,
I am the Clinical Pharmacist at a womens health clinic group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a serious adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Adverse event report Product A plus suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am the Consultant Haematologist at a rehabilitation and long-term care facility and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adver... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A suspected adverse reaction with Product B no current exposure
Dear Adverse Events Reporting Centre,
I am the Clinical Pharmacy Director at a specialist neurology centre and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an ad... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Product A reaction and dual drug reaction Product A and Omeprazole formal notification
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Formal adverse event notification Product A with Amoxicillin also suspected by physician
Dear Drug Safety Department,
I am the Clinical Pharmacy Director at a dialysis centre network and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Serious adverse event report Product A and suspected combined effect Product A and Amlodipine
Dear Patient Safety Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Formal adverse event notification Product A with Atorvastatin maintained as background medication
To Whom It May Concern,
I am writing as the caregiver for my wife Mark Fisher to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient expe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Adverse reaction report involving Product A and Metformin maintained as background medication
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my wife Katherine Hill to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Serious adverse event report Product A and Omeprazole taken concurrently not suspected
Hi,
I am the Consultant Rheumatologist at a hepatology referral centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 55 ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A reaction and Product B stopped before symptoms began formal notification
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Cardiologist at a residential care home network managing over 400 elderly residents across 5 facilities and I am writing to formally report an adverse event involv... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Safety report Product A and suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as cont... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Pharmacovigilance report Product A with Product B no current exposure
Good morning,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 42 year old male patient on Product A for 20 weeks who pre... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A reaction and continued Product B administration formal notification
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 45 ye... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Urgent adverse event Product A and Atorvastatin stable during Product A reaction
Dear Regional Pharmacovigilance Lead,
I am the Consultant Gastroenterologist at a cancer centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. Th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A adverse event and Ibuprofen concomitant medication only report
Dear Clinical Safety and Regulatory Affairs,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 62 year old male patient... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 62 year old male patient initiated on Product A 8 weeks ago for an autoimmune skin condition who has developed severely elevated liver enzymes confirmed on blood testing, ... |
SUBJECT: Adverse event report Product A plus suspect Product A with suspect Amlodipine
Dear Pharmacovigilance Team,
I am the Director of Clinical Services at a large endocrinology centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse ev... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A suspected adverse reaction with concurrent Product B use
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Pulmonologist at a private cardiology practice group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. Th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Urgent adverse event Product A and Product B prior use not relevant
Dear Regional Pharmacovigilance Lead,
I am the Consultant Neurologist at a respiratory medicine centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient expe... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 53 year old female patient started on Product A 7 weeks ago who developed profound fatigue, pallor, and symptomatic anaemia with haemoglobin of 7, qualifying as an Adverse... |
SUBJECT: Product A suspected adverse reaction with Product A and Methotrexate both implicated
Dear Drug Safety Department,
I am the Senior Nurse Practitioner at a Veterans Affairs medical centre and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report a serious advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A suspected reaction with Product B stable throughout event – formal report
Dear Pharmacovigilance and Risk Management Team,
I am the Director of Clinical Services at a private oncology clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish t... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Urgent adverse event Product A and Amlodipine also suspected by physician
Good morning,
I am the Chief of Medicine at a managed care organisation and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a serious adverse event where the treating physician... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Adverse event notification for Product A with concomitant Product B therapy
Dear Medical Affairs and Drug Safety,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 67 year old female patient i... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Formal adverse event notification Product A with Product B no current exposure
Dear Corporate Drug Safety Department,
I am the Clinical Pharmacy Director at a corporate occupational health provider and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I w... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A reaction and suspect Product B also implicated formal notification
Dear Corporate Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both med... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A suspected reaction with concomitant Product B exposure – formal report
Dear Medical Affairs and Drug Safety,
I am the Consultant Pulmonologist at a pathology and diagnostics consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A suspected reaction with Product B stopped months ago – formal report
Dear Clinical Safety and Regulatory Affairs,
I am the Clinical Nurse Specialist at a pharmaceutical benefit manager and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adve... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A suspected reaction with Product B unchanged during reaction – formal report
Dear Corporate Drug Safety Department,
I am writing as the caregiver for my husband Patricia Perry to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Urgent adverse event Product A and Amlodipine not implicated in adverse event
Hi,
I am the Chief of Medicine at a rheumatology clinic group and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patient experienced a 64 year old ma... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A reaction and concomitant Product B therapy formal notification
Dear Medical Affairs and Drug Safety,
I am the Chief of Medicine at a geriatric medicine consortium and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Product A reaction report with Product B stable throughout event
Hi,
I am the Pharmacy Operations Manager at a pain management clinic group and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The patient experienced a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Serious adverse event report Product A and Product B as background therapy
Dear Regional Pharmacovigilance Lead,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 55 year ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Pharmacovigilance report Product A with both Product A and Levothyroxine identified as suspect
Dear Corporate Drug Safety Department,
I am the Consultant Hepatologist at a Veterans Affairs medical centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse reaction report involving Product A and previous Product B therapy
Dear Global Safety Unit,
I am the Senior Consultant at a specialist dermatology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse reaction report involving Product A and Product B maintained during event
Hi,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 34 year old female patient on Product A for 10 weeks who... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Product A reaction report with concomitant Product B therapy
To Whom It May Concern,
I am the Consultant Hepatologist at a multi-site primary care network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a 73 yea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Pharmacovigilance report Product A with Amoxicillin excluded as causative agent
Dear Pharmacovigilance Team,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 67 year old ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Suspected adverse event with Product A and dual drug reaction Product A and Atorvastatin
To Whom It May Concern,
I am the Consultant Rheumatologist at a pain management clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Suspected adverse event with Product A and dual drug reaction Product A and Lisinopril
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Gastroenterologist at an integrated care system and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Product A reaction report with Product B discontinued prior to event
Good morning,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 45 year old female patient initiated o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Adverse reaction report involving Product A and Product B stopped before symptoms began
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 55 year old fema... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Adverse reaction report involving Product A and Product B stopped before symptoms began
Dear Corporate Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 76 year old fem... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Adverse event report Product A plus Product B historical medication only
Dear Patient Safety Team,
I am the Senior Nurse Practitioner at a clinical research site network and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient ex... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse event notification for Product A with Product B implicated only as concomitant
Dear Patient Safety Team,
I am the Consultant Endocrinologist at a rural district hospital and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A suspected adverse reaction with Product B as background therapy
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 55 year old female patient who... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A suspected reaction with Amoxicillin not implicated in adverse event – formal report
Dear Post-Marketing Surveillance Unit,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 67 year o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Safety report Product A and both Product A and Atorvastatin identified as suspect
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Gastroenterologist at a large endocrinology centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a s... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A adverse reaction with Omeprazole taken concurrently not suspected
Dear Global Safety Unit,
I am writing as the caregiver for my wife Gregory Berry to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 48 year o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A suspected reaction with suspect Product B also implicated – formal report
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects bo... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 67 year old female patient initiated on Product A 9 weeks ago who developed a severe generalized maculopapular rash covering more than 50% of body surface area, facial swe... |
SUBJECT: Adverse event notification for Product A with Omeprazole unchanged during event onset
Dear Adverse Events Reporting Centre,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 60 year old male p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Suspected adverse event with Product A and Amoxicillin stable during Product A reaction
Dear Clinical Safety and Regulatory Affairs,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 48 year o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 48 year old female patient on Product A for 14 weeks who presented with new-onset shortness of breath, dry cough, and bilateral pulmonary infiltrates on chest imaging cons... |
SUBJECT: Product A adverse event and previous Product B therapy report
Good morning,
I am writing as the caregiver for my husband Jessica Fox to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 37 year old female patient initia... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Dear Corporate Drug Safety Department,
I am the Consultant Haematologist at a respiratory medicine centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as a suspect drug.... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
To Whom It May Concern,
I am the Consultant Haematologist at a mental health trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating ph... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Adverse reaction report involving Product A and suspected combined effect Product A and Methotrexate
Dear Regional Pharmacovigilance Lead,
I am the Director of Clinical Services at a pharmaceutical benefit manager and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Formal adverse event notification Product A with Product B historical exposure documented
Dear Clinical Safety and Regulatory Affairs,
I am the Consultant Neurologist at a regional hospital trust and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an advers... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 64 year old male patient on Product A for 13 weeks who developed progressive dysphagia, odynophagia, and severe oesophageal ulceration on endoscopy, qualifying as an Adver... |
SUBJECT: Safety report Product A and Product B implicated only as concomitant
Dear Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 55 year old female patient who was started o... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A suspected adverse reaction with Product B stopped months ago
Dear Regional Pharmacovigilance Lead,
I am the Consultant Neurologist at a cancer centre network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Pharmacovigilance report Product A with Lisinopril excluded as causative agent
Dear Corporate Drug Safety Department,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report an adverse event. The patient experienced a 29 ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Adverse event notification for Product A with suspected combined effect Product A and Methotrexate
Hi,
I am writing as the caregiver for my husband Sharon Castro to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating physi... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Pharmacovigilance report Product A with Methotrexate continued without change
Hi,
I am the Clinical Pharmacy Director at a gastroenterology clinic partnership and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The pat... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 68 year old male patient started on Product A 5 weeks ago for rheumatoid arthritis who developed acute confusion, fever to 39, qualifying as an Adverse Event with Product ... |
SUBJECT: Product A adverse event and dual drug reaction Product A and Atorvastatin report
Dear Drug Safety Department,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medicatio... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Formal adverse event notification Product A with suspect Product B also implicated
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my wife Anthony Nelson to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Adverse event notification for Product A with suspect Product B also implicated
Dear Pharmacovigilance Team,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medication... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Serious adverse event report Product A and Methotrexate excluded as causative agent
Good morning,
I am the Consultant Hepatologist at a rheumatology clinic group and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experienced a... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Product A adverse reaction with suspect Product B also implicated
Dear Adverse Events Reporting Centre,
I am writing on behalf of a patient group member to report an adverse event involving a medication that was recently initiated.
I wish to report a serious adverse event where the treating physician suspects... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 37 year old female patient initiated on Product A 8 weeks ago who developed severe headache, visual field defects, and magnetic resonance imaging confirmed cerebral venous... |
SUBJECT: Pharmacovigilance report Product A with concomitant Product B exposure
To Whom It May Concern,
I am the Director of Clinical Services at a home healthcare nursing agency and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report an adverse event. The patien... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 45 year old female patient initiated on Product A 10 weeks ago who developed severe depression with suicidal ideation, insomnia, and anhedonia requiring urgent psychiatric... |
SUBJECT: Product A reaction report with physician suspects both Product A and Levothyroxine
Dear Global Safety Unit,
I am writing as the caregiver for my father Frank Olson to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the treating phy... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Product A adverse reaction with dual suspect Product A and Amlodipine
Hi,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report a serious adverse event where the treating physician suspects both medications as contributory factors. The pati... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 42 year old male patient on Product A for 20 weeks who presented with new visual disturbances, blurred vision, and bilateral optic disc swelling on ophthalmic examination,... |
SUBJECT: Serious adverse event report Product A and suspect Product B also implicated
Dear Regional Pharmacovigilance Lead,
I am writing as the caregiver for my father Joseph Arnold to report an adverse reaction they experienced with a recently started medication.
I wish to report a serious adverse event where the tre... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Product A reaction report with Product B implicated only as concomitant
Dear Sir or Madam,
I am the Ward Nurse Manager at a paediatric outpatient service and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. The patient experienced a 76 y... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 76 year old female patient on Product A for 6 weeks who experienced syncopal episodes, documented bradycardia with heart rate 38 bpm, and dizziness requiring emergency dep... |
SUBJECT: Product A suspected reaction with Product B unchanged during reaction – formal report
Dear Pharmacovigilance and Risk Management Team,
I am writing as the caregiver for my mother Aaron Hunt to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. Th... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 55 year old female patient who was started on Product A 11 weeks ago for a chronic inflammatory condition, qualifying as an Adverse Event with Product A as the suspect dru... |
SUBJECT: Product A reaction report with Amoxicillin excluded as causative agent
Dear Sir or Madam,
I am the Clinical Pharmacy Director at a geriatric medicine consortium and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to report an adverse event. The p... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 59 year old male patient on Product A for 16 weeks who developed progressive peripheral neuropathy affecting both hands and feet with numbness, tingling, and loss of propr... |
SUBJECT: Product A suspected reaction with ongoing Ibuprofen use alongside Product A – formal report
To Whom It May Concern,
I am the Clinical Nurse Specialist at a womens health clinic group and I am documenting this adverse event report on behalf of a patient under our ward care.
I wish to report an adverse event. T... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Suspected adverse event with Product A and Product B stopped before symptoms began
Dear Clinical Safety and Regulatory Affairs,
I am writing as the caregiver for my wife Deborah Schmidt to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The pa... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "95%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Pharmacovigilance report Product A with physician suspects both Product A and Ibuprofen
Dear Pharmacovigilance and Risk Management Team,
I am the Chief of Medicine at a hepatology referral centre and I am formally notifying you of an adverse event report requiring pharmacovigilance review.
I wish to report a ... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 38 year old male patient on Product A for 12 weeks who developed acute kidney injury with serum creatinine rising from baseline 89 umol/L to 312 umol/L and reduced urine o... |
SUBJECT: Suspected adverse event with Product A and dual suspect Product A and Ibuprofen
Dear Medical Affairs and Drug Safety,
I am the Pharmacy Operations Manager at a geriatric medicine consortium and I am submitting this adverse event report on behalf of a patient who presented to our pharmacy services.
I wish to r... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 41 year old female patient on Product A for 11 weeks who experienced recurrent pancreatitis with severe epigastric pain, serum lipase 12 times upper limit of normal, and c... |
SUBJECT: Urgent adverse event Product A and concomitant Product B exposure
Dear Medical Affairs and Drug Safety,
I am writing as the caregiver for my wife Ashley Thomas to report an adverse reaction they experienced with a recently started medication.
I wish to report an adverse event. The patient experienced a 29 yea... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "98%"}, "Analysis": "The email reports an adverse event a 29 year old female patient started on Product A 4 weeks ago who experienced anaphylaxis within 30 minutes of dosing including urticaria, angioedema, bronchospasm, and hypo... |
SUBJECT: Product A reaction report with suspect Product B also implicated
Good morning,
I am the Consultant Haematologist at a geriatric medicine consortium and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event where the treating physician susp... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 50 year old female patient on Product A for 15 weeks who developed severe arthralgia involving multiple joints with morning stiffness exceeding 2 hours and elevated inflam... |
SUBJECT: Product A suspected adverse reaction with Amlodipine taken concurrently not suspected
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Endocrinologist at a chain of retail pharmacies and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 34 year old female patient on Product A for 10 weeks who experienced severe abdominal pain, bloody diarrhoea more than 8 episodes per day, and colitis confirmed on flexibl... |
SUBJECT: Adverse event notification for Product A with concomitant Atorvastatin therapy
Hi,
I am writing to report an adverse reaction I have experienced with a medication I was recently prescribed.
I wish to report an adverse event. The patient experienced a 60 year old male patient on Product A for 9 weeks who devel... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
SUBJECT: Product A reaction and Lisinopril stable during Product A reaction formal notification
Good morning,
I am the Consultant Rheumatologist at a tertiary referral hospital and I am writing to formally report an adverse event involving a patient under my care.
I wish to report an adverse event. The patient experie... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Product A adverse reaction with Product A and Amlodipine both implicated
Dear Post-Marketing Surveillance Unit,
I am the Consultant Cardiologist at a hepatology referral centre and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a serious adverse event wher... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 73 year old male patient started on Product A 6 weeks ago who developed severe thrombocytopenia with platelet count 12 x10^9/L and mucosal bleeding, qualifying as an Adver... |
SUBJECT: Suspected adverse event with Product A and suspect Product B also implicated
Dear Pharmacovigilance and Risk Management Team,
I am the Consultant Dermatologist at a multi-site primary care network and I am writing to formally report an adverse event involving a patient under my care.
I wish to report a seriou... | {"Classification_of_request": {"Classification": "Adverse Event", "Confidence_percentage": "96%"}, "Analysis": "The email reports an adverse event a 60 year old male patient on Product A for 9 weeks who developed severe photosensitivity with blistering sunburn-like reaction on sun-exposed skin and skin biopsy showing v... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.